CD8A and neoplasm: While TNFR1, FADD and caspase-8 have been crucially implicated in the killing of tumor cells by CD8+ T cells and NK cells, the LUBAC components were found to antagonize the latter (Kearney et al., 2018; Zhang et al., 2022).